MediWound director logs offsetting 525-share trades
MediWound Ltd. (MDWD) director Samuel Rubinstein reported offsetting indirect trades in ordinary shares held by his spouse on September 1, 2026, selling 525 shares at $12.72 and purchasing 525 shares at $12.62, resulting in no net change in share count.
Rhea-AI Filing Summary
MediWound Ltd. (MDWD) director Samuel Rubinstein reported offsetting indirect trades in ordinary shares held by his spouse on September 1, 2026, selling 525 shares at $12.72 and purchasing 525 shares at $12.62, resulting in no net change in share count. The filing also lists existing equity holdings, including stock options to acquire ordinary shares with exercise prices of $9.64, $12.73, $18.54 and $17.60, covering 7,200; 7,542; 5,600; and 6,250 underlying shares, respectively, plus ordinary shares underlying RSUs that vest one year after a March 4, 2026 grant. Several rows are explicitly described as informational only, with no transactions effected, and no Rule 10b5-1 trading plan is reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
8 transactions reported
Mixed
8 txns
Insider
Rubinstein Samuel
Role
Director
Bought
525 shs ($7K)
Sold
525 shs ($7K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Ordinary Shares | 525 | $12.72 | $7K |
| Purchase | Ordinary Shares | 525 | $12.62 | $7K |
| holding | Stock Option (right to buy ordinary shares) F2 | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) F2 | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) F2 | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) F2, F3 | -- | -- | -- |
| holding | Ordinary Shares F2 | -- | -- | -- |
| holding | Ordinary shares F1, F2 | -- | -- | -- |
Holdings After Transaction:
Ordinary Shares — 525 shares (Indirect, By spouse);
Stock Option (right to buy ordinary shares) — 26,592 contracts (Direct);
Ordinary Shares — 3,743 shares (Direct)
Footnotes (3)
- F1. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.
- F2. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
- F3. The options reported in this row were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.
Key Figures
Shares sold: 525 ordinary shares
Sale price: $12.72 per share
Shares purchased: 525 ordinary shares
+5 more
8 metrics
Shares sold
525 ordinary shares
Indirect sale by spouse on September 1, 2026
Sale price
$12.72 per share
Indirect sale of 525 ordinary shares on September 1, 2026
Shares purchased
525 ordinary shares
Indirect purchase by spouse on September 1, 2026
Purchase price
$12.62 per share
Indirect purchase of 525 ordinary shares on September 1, 2026
Option strike price
$9.64
Stock option over 7,200 underlying ordinary shares expiring August 15, 2033
Option strike price
$12.73
Stock option over 7,542 underlying ordinary shares expiring February 26, 2034
Option strike price
$18.54
Stock option over 5,600 underlying ordinary shares expiring February 11, 2035
Option strike price
$17.60
Stock option over 6,250 underlying ordinary shares expiring March 4, 2036
Key Terms
foreign private issuer, short-swing profit recovery provisions, Section 16(b), restricted stock units (RSUs)
4 terms
foreign private issuer regulatory
"The Issuer is a foreign private issuer as defined under Rule 3b-4"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
short-swing profit recovery provisions regulatory
"the Reporting Person is exempt from the short-swing profit recovery provisions"
Section 16(b) regulatory
"short-swing profit recovery provisions of Section 16(b) of the Exchange Act"
A federal rule that requires company insiders—like officers, directors and large shareholders—to return any profits made from buying and selling the company’s stock within a six-month window. It matters to investors because it discourages short-term trades that could exploit non-public information and helps protect outside shareholders by creating a simple, enforceable way to recover unfair gains, much like a rule stopping someone from flipping a limited-edition item for quick profit after getting early access.
restricted stock units (RSUs) financial
"consist of shares underlying RSUs that were granted to the Reporting Person"
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
FAQ
What transactions did MDWD director Samuel Rubinstein report on September 1, 2026?
He reported an indirect sale of 525 ordinary shares at $12.72 and an indirect purchase of 525 ordinary shares at $12.62, both through his spouse, resulting in no net change in total shares.
Were the MDWD Form 4 trades made under a Rule 10b5-1 plan?
No. The filing indicates that no Rule 10b5-1 trading plan is reported for these transactions; the document-level checkbox for such a plan is explicitly unchecked.
What MDWD stock options does Samuel Rubinstein hold according to this Form 4?
He holds options over ordinary shares with exercise prices of $9.64 (7,200 underlying shares), $12.73 (7,542), $18.54 (5,600), and $17.60 (6,250), expiring between August 15, 2033 and March 4, 2036.
What does the Form 4 say about Samuel Rubinstein’s RSUs in MDWD?
One holding row represents ordinary shares underlying RSUs granted on March 4, 2026, which vest 100% on the one-year anniversary of the grant date. That row is a holding only and does not reflect a new transaction.
Are all the securities rows in this MDWD Form 4 actual trades?
No. Several rows, including certain ordinary share and option holdings, are footnoted as informational only, stating that no transactions were effected for those securities; they simply disclose existing positions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
